Literature DB >> 21109700

Efficacy of omalizumab in the treatment of nasal polyps.

María del Carmen Vennera, César Picado, Joaquim Mullol, Isam Alobid, Manuel Bernal-Sprekelsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21109700     DOI： 10.1136/thx.2010.152835

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  22 in total

Review 1.  Role of medical therapy in the management of nasal polyps.

Authors:  Isam Alobid; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

Review 2.  Off-Label Uses of Omalizumab.

Authors:  David El-Qutob
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 3.  Current and Future Treatments of Rhinitis and Sinusitis.

Authors:  Gayatri B Patel; Robert C Kern; Jonathan A Bernstein; Park Hae-Sim; Anju T Peters
Journal:  J Allergy Clin Immunol Pract       Date:  2020-01-28

Review 4.  Biologics in chronic rhinosinusitis with nasal polyposis.

Authors:  Tanya M Laidlaw; Kathleen M Buchheit
Journal:  Ann Allergy Asthma Immunol       Date:  2019-12-09       Impact factor: 6.347

Review 5.  Omalizumab for severe asthma: efficacy beyond the atopic patient?

Authors:  Christian Domingo
Journal:  Drugs       Date:  2014-04       Impact factor: 9.546

Review 6.  Contemporary Pharmacotherapy for Allergic Rhinitis and Chronic Rhinosinusitis.

Authors:  Saied Ghadersohi; Bruce K Tan
Journal:  Otolaryngol Clin North Am       Date:  2017-09-28       Impact factor: 3.346

7.  ICON: chronic rhinosinusitis.

Authors:  Claus Bachert; Ruby Pawankar; Luo Zhang; Chaweewan Bunnag; Wytske J Fokkens; Daniel L Hamilos; Orathai Jirapongsananuruk; Robert Kern; Eli O Meltzer; Joaquim Mullol; Robert Naclerio; Renata Pilan; Chae-Seo Rhee; Harumi Suzaki; Richard Voegels; Michael Blaiss
Journal:  World Allergy Organ J       Date:  2014-10-27       Impact factor: 4.084

Review 8.  What we know about nonsteroidal anti-inflammatory drug hypersensitivity.

Authors:  Duy Le Pham; Ji-Hye Kim; Tu Hoang Kim Trinh; Hae-Sim Park
Journal:  Korean J Intern Med       Date:  2016-03-31       Impact factor: 2.884

Review 9.  Pathophysiology of chronic rhinosinusitis, pharmaceutical therapy options.

Authors:  Claus Bachert; Gabriële Holtappels
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

Review 10.  Anti-IgE monoclonal antibody therapy for the treatment of chronic rhinosinusitis: a systematic review.

Authors:  Chris J Hong; Adrian C Tsang; Jason G Quinn; James P Bonaparte; Adrienne Stevens; Shaun J Kilty
Journal:  Syst Rev       Date:  2015-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.